Researchers from Tel Aviv University and the Israel Institute for Biological Research in Ness Ziona have used the platform developed for COVID-19 vaccines to create the world's first mRNA-based ...

German biotech firm CureVac has taken Moderna to court in Delaware, claiming the American drugmaker’s blockbuster Spikevax ...

Health and Human Services Secretary Robert F. Kennedy Jr. revealed his agency will be cutting funding to mRNA development, calling the vaccine technology "ineffective" and claiming it poses more risks ...

Health care workers wheel a Covid-19 patient through a hallway at the Southwestern Vermont Medical Center in Bennington on Dec. 13, 2021. Photo by Glenn Russell/VTDigger This is the first story in a ...

German biotech company CureVac sued Moderna in Delaware federal court on Friday, alleging that Moderna's ​COVID-19 vaccine ...

Respiratory viruses that have diverse strains and mutate rapidly, such as influenza and COVID-19, are difficult to block perfectly with vaccines alone. To solve this problem, KAIST's research team has ...

Dallas and Austin are part of a worldwide clinical trial underway to find a more effective treatment to lower the recurrence of melanoma or high-risk skin cancer. It involves a highly advertised drug ...

Nirmatrelvir in combination with ritonavir is an antiviral treatment for mild-to-moderate coronavirus disease 2019 (Covid-19). The efficacy of this treatment in patients who are at standard risk for ...

Key market opportunities include advancing rapid, high-throughput testing kits and integrating digital reporting, enhancing ...